Primary Objective: To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergic potential (sensibilization) of the product Dermacyd Infantile.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
Dermacyd Infantile (Lactic Acid)
Sanofi-Aventis Administrative Office
São Paulo, Brazil
The absence of primary and accumulated dermic irritability and dermic sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.
Time frame: During 6 weeks (i.e. treatment period)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.